Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 251

The DOI matches its Crossref record.

Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty‐five patients

Guillevin, Loïc, Cohen, Pascal, Mahr, Alfred, Arène, Jean‐Pierre, Mouthon, Luc, Puéchal, Xavier, Pertuiset, Edouard, Gilson, Brigitte, Hamidou, Mohamed, Lanoux, Patricia, Bruet, Alain, Ruivard, Marc, Vanhille, Philippe, Cordier, Jean‐François·2003·Arthritis Care & Research

Abstract

Objective: Because the optimal cyclophosphamide (CY) treatment duration for severe polyarteritis nodosa (PAN) without virus infection and microscopic polyangiitis (MPA) has not been established, we conducted a trial to compare the effectiveness of 6 versus 12 CY pulses given in combination with corticosteroids (CS). Methods: Sixty‐five (18 PAN, 47 MPA) previously untreated patients were randomized to receive 12 (n = 34) or 6 (n = 31) CY pulses combined with CS. PAN and MPA were histologically proven or met ACR criteria. All patients presented ≥1 factor of severity according to the five factor score (FFS). CY pulses were administered every 2 weeks for 1 month, then every 4 weeks. The end point of the study was the number of events (relapses and/or deaths) occurring in each group, analyzed according to an intention‐to‐treat strategy. The outcome was evaluated by Cox proportional hazards analysis. Results: The baseline characteristics were similar for both groups. The mean (± SD) followup was 32 ± 21 months. Survival analysis showed a significantly lower relapse probability (P = 0.02; hazards ratio [HR] = 0.34) and higher event‐free survival (P = 0.02, HR = 0.44) for the 12 CY‐pulse group while the mortality rates were not significantly different (P = 0.47). Conclusion: These results suggest that 6 CY pulses are less effective than 12 CY pulses to treat severe PAN and MPA, particularly with respect to the risk of relapses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.10922

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 21

  1. 10.1002/art.1780370206 · DOI · Paper page
  2. 10.1016/S0140-6736(97)80118-3 · DOI · Paper page
  3. 10.1002/art.1780330805 · DOI
  4. 10.1097/00005792-199601000-00003 · DOI · Paper page
  5. 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A · DOI · Paper page
  6. 10.7326/0003-4819-116-6-488 · DOI · Paper page
  7. Luqmani R, 1999, A multicenter randomised trial of cyclophosphamide versus azathioprine during remission in ANCA‐associated vasculitis (CYCAZAREM), Arthritis Rheum, 42, S225
  8. 10.1093/qjmed/90.6.401 · DOI · Paper page
  9. 10.1002/art.1780401213 · DOI · Paper page
  10. Guillevin L, 1992, Treatment of polyarteritis nodosa and Churg‐Strauss syndrome: a meta‐analysis of 3 prospective controlled trials including 182 patients over 12 years, Ann Méd Interne (Paris), 143, 405
  11. 10.1093/rheumatology/36.12.1290 · DOI · Paper page
  12. 10.1097/00005792-199509000-00002 · doi:10.1097/00005792-199509000-00002
  13. Luqmani RA, 1994, Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis, Q J Med, 87, 671
  14. 10.1046/j.1523-1755.1998.00807.x · DOI · Paper page
  15. 10.1080/01621459.1958.10501452 · DOI · Paper page
  16. Cox D, 1972, Regression models and life tables, J R Stat Soc, 34, 187
  17. 10.1002/art.1780381116 · DOI · Paper page
  18. 10.1002/1529-0131(200012)43:12<2853::AID-ANR30>3.0.CO;2-G · doi:10.1002/1529-0131(200012)43:12<2853::aid-anr30>3.0.co;2-g
  19. Bartolucci P, 2001, Pilot study on infliximab for 10 patients with systemic vasculitis not responding to steroids and immunosuppressants, Arthritis Rheum, 44, S56
  20. Lamprecht P, 2001, Successful treatment of refractory Wegener's granulomatosis with infliximab, Arthritis Rheum, 44, S56
  21. Bacon PA, 1998, Immune ablation with peripheral blood stem cell rescue in Wegener's systemic vasculitis, Clin Exp Immunol, 112, S57

Cited by

See all 251

Metadata

Authors
Guillevin, L., Cohen, P., Mahr, A., Arène, J., Mouthon, L., Puéchal, X., Pertuiset, E., Gilson, B., Hamidou, M., Lanoux, P., Bruet, A., Ruivard, M., Vanhille, P., & Cordier, J.
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2003-02-07
Volume
49
Issue
1
Pages
93-100
ISSN
  • 0893-7524 (ISSN-L)
  • 1529-0123
OpenAlex
W2022541722
Cited by
251
References
0
FWCI
9.39
Type
journal article
Language
en
Open access
closed
Funders
  • Hospices Civils de Lyon
  • Association pour la Recherche sur les Angéites Nécrosantes (ARAN)
  • UPRES EA-3409 Recherche clinique et thérapeutique
  • Université de Paris-Nord

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty‐five patients. https://app.cochat.ai/papers/10.1002/art.10922
The paper
Guillevin, L., Cohen, P., Mahr, A., Arène, J., Mouthon, L., Puéchal, X., Pertuiset, E., Gilson, B., Hamidou, M., Lanoux, P., Bruet, A., Ruivard, M., Vanhille, P., & Cordier, J. (2003). Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty‐five patients. Arthritis Care & Research. https://doi.org/10.1002/art.10922

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.